1. Aleshin S, Grabeklis S, Hanck T et al. Peroxisome proliferator-activated receptor PPAR-gamma positively controls. Mol Pharmacol 2009; 76: 414–24.
2. Arakawa R, Tsujita M, Iwamoto N et al. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J Lipid Res 2009; 50: 2299–305.
3. Ko YG, Kim BK, Lee BK et al. Study design and rational of SECURE-study: a double-blind randomised controlled multicenter clinical trial. Trials 2011; 12 (1): 10.
4. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 2009;108: 1447–52.
5. Sastry P, Kaski JC. Atherosclerotic plaque regression – the role of statin therapy. Drugs Today 2010; 46 (8): 601–8.
6. Люсов В.А., Таратухин Е.О. Перспективы антитромбоцитарной терапии. Рос. кардиол. журн. 2011; 1.
Авторы
Е.О.Таратухин
Кафедра госпитальной терапии №1 лечебного факультета ГБОУ ВПО РНИМУ им. Н.И.Пирогова, Москва